Ticker Launch

SPAC · Deal announced · APXI

APx Acquisition Corp. I

Business combination with OmnigenicsAI Corp

APx Acquisition Corp. I (APXI) is a blank-check company (SPAC) that raised $150M in its initial public offering on Dec 8, 2021, listing on Nasdaq. It agreed to combine with OmnigenicsAI Corp, announced on Mar 25, 2024. The deal has not closed yet. AC Capital led the IPO, with VRE Capital. Davis Polk advised the SPAC and A&O Shearman advised the underwriters on the IPO.

Status
Deal announced
Ticker
APXI
IPO date
Dec 8, 2021
IPO size
$150M
IPO exchange
Nasdaq
Target
OmnigenicsAI Corp
Target sector
Other
Announced
Mar 25, 2024
Combined company
OmnigenicsAI Corp
IPO underwriters
AC Capital and VRE Capital
SPAC counsel (IPO)
Davis Polk and Maples and Calder
Underwriters' counsel (IPO)
A&O Shearman

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other pending SPAC mergers